Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
Not reported
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Used in risk assessment report for zinc sulphate, acceptable for assessment.
Justification for type of information:
See appendix on read across in iuclid section 13
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1973

Materials and methods

Principles of method if other than guideline:
Female CD-1 mice were administered daily doses of 0.3, 1.4, 6.5 and 30 mg ZnSO4/kg bw by gavage during days 6-15 of gestation to evaluate the developmental toxicity of zinc sulphate.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Zinc sulphate
EC Number:
231-793-3
EC Name:
Zinc sulphate
Cas Number:
7733-02-0
Molecular formula:
H2O4S.Zn
IUPAC Name:
zinc sulfate
Details on test material:
zinc stock solutions (100 mg/L) were prepared from their respective sulfate salts (AR grade, Ajax Chemicals) in Milli-Q water and acidified by the addition of 10 ml HCl (Suprapur grade, Merck) per liter.

Test animals

Species:
mouse
Strain:
CD-1

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Analytical verification of doses or concentrations:
not specified
Details on mating procedure:
No data
Duration of treatment / exposure:
Day 6-15 of gestation
Frequency of treatment:
Daily
Duration of test:
no data
No. of animals per sex per dose:
25-30 animals/group
Control animals:
yes

Results and discussion

Results: maternal animals

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
30 mg/kg bw/day (nominal)
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects

Effect levels (fetuses)

Dose descriptor:
NOAEL
Effect level:
30 mg/kg bw/day (nominal)
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

- No clearly discernible effects on maternal survival, body weight gains, number of corpora lutea, implantations and resorptions were observed.

- The number of live litters, live and dead foetuses, the foetus weights and sex ratio were not affected by treatment.

- No difference in number or kind of abnormalities (in either soft or skeletal tissues) was found between exposed and control groups.

Applicant's summary and conclusion

Conclusions:
Under the conditions of the test, administration of up to 30 mg/kg bw of ZnSO4 (ca.12 mg or 6.8 mg Zn2+/kg bw, for anhydrate and heptahydrate, respectively) had no adverse effects on adult mice and their foetuses.
Executive summary:

Female CD-1 mice (25-30 animals/group) received daily doses of 0.3, 1.4, 6.5 and 30 mg unspecified ZnSO4/kg bw by gavage during days 6-15 of gestation. A control group was included. All animals were observed daily for appearance and behaviour with particular attention to food consumption and body weight. Body weights were recorded on day 0, 6, 11, 15 and 17 of gestation. The females were sacrificed at day 17. The urogenital tract of each animal was examined in detail.

No clearly discernible effects on maternal survival, body weight gains, number of corpora lutea, implantations and resorptions were observed. The number of live litters, live and dead foetuses, the foetus weights and sex ratio were not affected by treatment. No difference in number or kind of abnormalities (in either soft or skeletal tissues) was found between exposed and control groups.

Under the conditions of the test,administration of up to 30 mg/kg bw of unspecified zinc sulphate (ca.12 mg or 6.8 mg Zn2+/kg bw, for anhydrate and heptahydrate, respectively) had no adverse effects on adult mice and their foetuses.